- Home
- FSM vs WVE Comparison
FSM vs WVE Comparison
Compare FSM & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSM
- WVE
- Stock Information
- Founded
- FSM 1990
- WVE 2012
- Country
- FSM Canada
- WVE Singapore
- Employees
- FSM N/A
- WVE N/A
- Industry
- FSM Precious Metals
- WVE Biotechnology: Pharmaceutical Preparations
- Sector
- FSM Basic Materials
- WVE Health Care
- Exchange
- FSM Nasdaq
- WVE Nasdaq
- Market Cap
- FSM 2.0B
- WVE 939.3M
- IPO Year
- FSM N/A
- WVE 2015
- Fundamental
- Price
- FSM $5.45
- WVE $6.52
- Analyst Decision
- FSM Hold
- WVE Strong Buy
- Analyst Count
- FSM 1
- WVE 11
- Target Price
- FSM $7.00
- WVE $20.91
- AVG Volume (30 Days)
- FSM 14.6M
- WVE 1.7M
- Earning Date
- FSM 05-07-2025
- WVE 05-08-2025
- Dividend Yield
- FSM N/A
- WVE N/A
- EPS Growth
- FSM N/A
- WVE N/A
- EPS
- FSM 0.51
- WVE N/A
- Revenue
- FSM $1,151,277,000.00
- WVE $104,939,000.00
- Revenue This Year
- FSM N/A
- WVE N/A
- Revenue Next Year
- FSM N/A
- WVE N/A
- P/E Ratio
- FSM $10.50
- WVE N/A
- Revenue Growth
- FSM 32.69
- WVE N/A
- 52 Week Low
- FSM $3.86
- WVE $4.25
- 52 Week High
- FSM $6.78
- WVE $16.74
- Technical
- Relative Strength Index (RSI)
- FSM 39.09
- WVE 43.25
- Support Level
- FSM $5.35
- WVE $5.62
- Resistance Level
- FSM $6.26
- WVE $6.73
- Average True Range (ATR)
- FSM 0.28
- WVE 0.60
- MACD
- FSM -0.10
- WVE 0.07
- Stochastic Oscillator
- FSM 7.01
- WVE 36.10
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.